Anemia
Conditions
Keywords
postpartum hemorrhage, red blood cell transfusion, health related quality of life
Brief summary
Postpartum haemorrhage (PPH) is one of the top five causes of maternal mortality in developed and developing countries. The most important treatment of PPH is red blood cell (RBC) transfusion. The decision whether to prescribe RBC transfusion is mostly based on postpartum haemoglobin (Hb) values. RBC transfusion should be aimed to reduce morbidity and especially to improve Health Related Quality of Life (HRQoL). The goal of the WOMB study is to assess the effect of RBC transfusion on HRQoL and to confirm the role of HRQoL in deciding whether RBC transfusion is necessary.
Detailed description
The WOMB study is a multicenter trial in patients with PPH, where a restrictive RBC transfusion policy will be compared with a more liberal RBC transfusion policy. Primary outcome in this study is fatigue measured with the MFI questionnaire. Inclusion criteria are: 1) 12-24 h after VD or CS; 2) 4.8 ≤Hb≤ 7.9 g/dL; 3) blood loss ≥ 1000mL or Hb decrease ≥ 1,9 g/dL; 4) age≥ 18 years; 5) no anaemic symptoms. Patients will be randomised for a RBC transfusion or not. The total follow-up period is 6 weeks. HRQoL will be measured at T=0 (12-24 hours postpartum) 3 days, 1, 3 and 6 weeks postpartum. At T=0 and 6 weeks postpartum Hb value will be measured. For the patients who receive a RBC transfusion, the effect of the RBC transfusion will be measured with the Hb value, Hct, platelet and leukocyte count, and the temperature of the patient before and after the RBC transfusion. The sample size is 500 patients: 250 allocated to a RBC transfusion and 250 patients allocated to a restrictive policy.
Interventions
OTHERRed blood cell transfusion
At least one unit of red blood cells will be administered. The target Hb value after transfusion is at least 8.7 g/dL.
Sponsors
Erasmus Medical Center
Sanquin Research & Blood Bank Divisions
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Women older than 18 years * 12-24 hours after delivery (vaginal or caesarean section) * Patients are in a clinical obstetric setting * Blood loss of more than 1000 mL or Hb decrease ≥ 1,9 g/dL * Hb value between 4.8 g/dL and 7.9 g/dL * Working knowledge of the national language * Written consent for participating this study (informed consent)
Exclusion criteria
* Patients with severe preeclampsia/ HELLP syndrome * RBC transfusion during or after delivery but before t=0 * Patients with malignancy * Patients with severe congenital haemolytic disease, like thalassemia or sickle cell disease * Patients with compromised immunological status, congenital or acquired by medical treatment or infectious disease (eg. HIV) * Severe active infectious disease at the time of proposed inclusion * Severe cardiac, pulmonary, neurological, metabolic or psychiatric co- morbidity (ASA II/III) at the time of proposed inclusion * Severe physical complaints (tachycardia of more than 100 bpm, dyspnoea, syncope, heart problems) at the time of intended inclusion * Peripartum death of the newborn, or the newborn being in critical condition on neonatal intensive care
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Physical Fatigue | on day 3 postpartum | measured with the MFI questionnaire |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Blood usage and the costs | delivery - six weeks postpartum | — |
| Hemoglobin increase after transfusion | before- after transfusion | Hb value and platelet count will be measured before and after red blood cell transfusion |
| Health related quality of life | delivery - six weeks postpartum | Health related quality of life measured with the following questionnaires: Euro-Qol, SF-36 and the MFI |
| Hospital stay | delivery - six weeks postpartum | the hospital stay after delivery will be compared between both arms. All admissions in the first 6 weeks postpartum will be registered |
| Physical complications (infections, thromboembolic events, hemodynamic events, cardiac events, neurologic events, secondary HPP, obstetric interventions, 'rescue' RBC transfusion) with WHO CTC grade 2 or more. | delivery - six weeks postpartum | all complications and admissions in the first 6 weeks postpartum will be registered |
| Heart beat, blood pressure, temperature | before- after transfusion | heart beat per minute, blood pressure, temperature will be measured before and after red blood cell transfusion |
Countries
Netherlands
Outcome results
None listed